Literature DB >> 12139247

Transposase-mediated construction of an integrated adeno-associated virus type 5 helper plasmid.

Richard H Smith1, Sandra A Afione, Robert M Kotin.   

Abstract

Adeno-associated viruses (AAVs) are replication-defective parvoviruses that require helper virusfunctionsfor efficient productive replication. The AAVs are currently premier candidates as vectors for human gene therapy applications. In particular; much recent interest has been expressed concerning recombinant AAV serotype 5 (rAAV-5) vectors, as they appear to utilize cellular receptors distinctfrom those of the prototypical AAV serotype (AAV-2) and have been reported to have transduction properties in vivo that differ significantly from those of the prototype. One of the most popular current methodsfor the production of rAAVs involves co-transfection of human 293 cells with three plasmids: (i) an adenovirus (Ad)-derived helper plasmid containing Ad genes required for AAV replication, (ii) an AAV-derived plasmid encoding complementing AAV genes (ie., the viral rep and cap genes), and (iii) a target plasmid containing a transgene of interestflanked by AAV inverted terminal repeats (ITRs) that confer packaging and replication capabilities upon the ITR-flanked heterologous DNA. Here we describe novel plasmid reagents designed for convenient and efficient production of rAAV-S. An integrated helper plasmid containing all Ad genes requiredfor the efficient production of recombinant AAV as well as the complementing AAV genes on the same plasmid backbone, was constructed via transposase-mediated insertion into an Ad helper plasmid of a transposable element containing the AAV-5 rep and cap genes linked to a selectable marker This simple strategy can be used in the rapid and efficient construction of integrated helper plasmids derived from any reported AAV serotype for which a molecular clone exists.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12139247     DOI: 10.2144/02331dd04

Source DB:  PubMed          Journal:  Biotechniques        ISSN: 0736-6205            Impact factor:   1.993


  11 in total

1.  Cloning and characterization of a bovine adeno-associated virus.

Authors:  Michael Schmidt; Hisako Katano; Ioannis Bossis; John A Chiorini
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

2.  Identification and characterization of novel adeno-associated virus isolates in ATCC virus stocks.

Authors:  Michael Schmidt; Emmanuelle Grot; Peter Cervenka; Sandra Wainer; Charles Buck; John A Chiorini
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

3.  Scalable generation of high-titer recombinant adeno-associated virus type 5 in insect cells.

Authors:  Masashi Urabe; Takayo Nakakura; Ke-Qin Xin; Yoko Obara; Hiroaki Mizukami; Akihiro Kume; Robert M Kotin; Keiya Ozawa
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

4.  Neutralizing antibodies against adeno-associated viruses in Sjögren's patients: implications for gene therapy.

Authors:  A Corden; B Handelman; H Yin; A Cotrim; I Alevizos; J A Chiorini
Journal:  Gene Ther       Date:  2017-02-02       Impact factor: 5.250

5.  Rescue of Adeno-Associated Virus Production by shRNA Cotransfection.

Authors:  Maria C Guimaro; Sandra A Afione; Tsutomu Tanaka; John A Chiorini
Journal:  Hum Gene Ther       Date:  2020-04-28       Impact factor: 5.695

6.  Gene-edited pseudogene resurrection corrects p47phox-deficient chronic granulomatous disease.

Authors:  Randall K Merling; Douglas B Kuhns; Colin L Sweeney; Xiaolin Wu; Sandra Burkett; Jessica Chu; Janet Lee; Sherry Koontz; Giovanni Di Pasquale; Sandra A Afione; John A Chiorini; Elizabeth M Kang; Uimook Choi; Suk See De Ravin; Harry L Malech
Journal:  Blood Adv       Date:  2016-12-28

7.  Liver transduction with recombinant adeno-associated virus is primarily restricted by capsid serotype not vector genotype.

Authors:  Dirk Grimm; Kusum Pandey; Hiroyuki Nakai; Theresa A Storm; Mark A Kay
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

8.  Identification and mutagenesis of the adeno-associated virus 5 sialic acid binding region.

Authors:  Sandra Afione; Michael A DiMattia; Sujata Halder; Giovanni Di Pasquale; Mavis Agbandje-McKenna; John A Chiorini
Journal:  J Virol       Date:  2014-11-19       Impact factor: 5.103

9.  Virus-mediated transduction of murine retina with adeno-associated virus: effects of viral capsid and genome size.

Authors:  Grace S Yang; Michael Schmidt; Ziying Yan; Jonathan D Lindbloom; Thomas C Harding; Brian A Donahue; John F Engelhardt; Robert Kotin; Beverly L Davidson
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

10.  Adeno-associated virus type 12 (AAV12): a novel AAV serotype with sialic acid- and heparan sulfate proteoglycan-independent transduction activity.

Authors:  Michael Schmidt; Antonis Voutetakis; Sandra Afione; Changyu Zheng; Danielle Mandikian; John A Chiorini
Journal:  J Virol       Date:  2007-11-28       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.